NewsLegislation
A federally funded review of the science on premium cigars is published
A federally funded review of the science on premium cigars was released, feeding straight into the regulatory fight.
Cigarero

In March 2022 a review of the scientific literature on premium cigars was published. It had been paid for by the FDA, and it was carried out by the National Academies, the body the American government turns to when it wants an independent reading of a field.
The review looked at what is actually known: how often premium cigars are smoked, by whom, and what the health evidence says about that pattern of use rather than about cigarettes. It found the research base thin and the conclusions that could be drawn from it limited.
That finding cut both ways. The industry read it as confirmation that the agency had regulated without evidence. The agency read it as a reason to gather more, and said so in the filings that followed.
The most useful part was structural. The review separated premium cigars from other tobacco products as an object of study, which the regulators had largely declined to do. From then on, any rule that treated the two as one had to answer for it.
It became a standard reference. The document is cited in the court cases that followed, on both sides, and it is still the first place anyone looking for what is known about premium cigars is sent.


